Brookfield Global Listed Infrastructure Income Fund Inc.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Brookfield Global Listed Infrastructure Income Fund Inc. Announces Terms of Rights Offering

NEW YORK, NEW YORK--(Marketwired - April 9, 2015) - Brookfield Global Listed Infrastructure Income Fund Inc. (the "Fund") (NYSE:INF) today announced that its Board of Directors approved the terms of a transferable rights offering which would allow the Fund's record date common shareholders to purchase additional shares of common stock.

The Board of Directors, based on the recommendations and presentations of Brookfield Investment Management Inc., the Fund's investment adviser (the "Adviser"), has determined that it is in the best interest of the Fund and its shareholders to increase the assets of the Fund available for investment and thereby to conduct the rights offering. The Adviser believes that now may be an opportune time to seek to take advantage of attractive investment opportunities and to further diversify the Fund's portfolio in global infrastructure securities, which may enable the Fund to potentially enhance yield and capture net asset value ("NAV") appreciation potential. Additionally, the rights offering seeks to provide existing shareholders the opportunity to acquire additional shares at a discount to the Fund's market price.

The record date of the rights offering is April 21, 2015. The rights offering is expected to expire on May 22, 2015, unless otherwise extended by the Fund (the "expiration date"). The rights will trade on the New York Stock Exchange ("NYSE") under the symbol "INF RT" until May 21, 2015, one business day prior to the expiration date.

Subject to the registration statement for the offer becoming effective under the Securities Act of 1933, the Fund will distribute to common shareholders of record one right for each common share held on the record date. This will allow common shareholders to purchase one new common share for every three rights held (1-for-3). Rights may be exercised only in multiples of three, except that record date common shareholders who are issued fewer than three rights will be entitled to subscribe for one common share of the Fund. Fractional common shares will not be issued. Common shares obtained through the exercise of rights by common shareholders will not be eligible to receive the Fund's monthly dividends to be paid in April and May 2015.

The subscription price per common share will be determined on the expiration date. The subscription price will be determined based on a formula equal to 90% of the average of the last reported sales price of a common share of the Fund on the NYSE on the expiration date and each of the four preceding trading days (the "formula price"). If, however, the formula price is less than 78% of the Fund's NAV per common share at the close of trading on the NYSE on the expiration date, the subscription price will be 78% of the Fund's NAV per common share at the close of trading on the NYSE on that day. The estimated subscription price has not yet been determined by the Fund.

Record date common shareholders who fully exercise all of their primary subscription rights will be eligible for an over-subscription privilege entitling those common shareholders to subscribe, subject to certain limitations and subject to allotment, for additional common shares covered by any unexercised rights.

The Fund expects to send each shareholder a prospectus for the offer and subscription certificates evidencing the rights offering to record date common shareholders within the United States following the record date. Common shareholders who hold their common shares through a broker, bank or trust company should contact their representative with instructions to either exercise or sell their rights. Common shareholders who hold common shares directly and wish to exercise or sell their rights should complete the subscription certificate they will receive in the mail and send it to the subscription agent for the offer, together with their payment, at one of the locations indicated on the subscription certificate or in the prospectus.

The Fund is a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended, and was organized as a corporation under the laws of the State of Maryland on June 8, 2011. The Fund's investment objective is to provide a high level of total return, with an emphasis on income.

Brookfield Investment Management Inc. is a registered investment advisor that invests in global listed real estate and infrastructure equities, corporate credit and securitized credit strategies. Headquartered in New York, NY, the Adviser and its affiliates also maintain offices and investment teams in Chicago, Boston and Toronto and had approximately $18 billion of assets under management as of December 31, 2014.The Adviser has experience in the management of institutional portfolios, retail mutual funds and various commingled vehicles. Brookfield Investment Management was established in 1989 and conducts the public market activities of Brookfield Asset Management Inc.

Brookfield Asset Management Inc. is a global alternative asset manager with over $200 billion in assets under management as of December 31, 2014. Brookfield has over a 100-year history of owning and operating assets with a focus on property, renewable power, infrastructure and private equity. The company offers a range of public and private investment products and services, which leverage its expertise and experience and provide it with a competitive advantage in the markets where it operates. Brookfield Global Listed Infrastructure Income Fund Inc. is managed by Brookfield Investment Management Inc.

The Fund uses its web site as a channel of distribution of material company information. Financial and other material information regarding the Fund is routinely posted on and accessible at www.brookfieldim.com .

COMPANY CONTACT
Brookfield Global Listed Infrastructure Income Fund Inc.
Brookfield Place
250 Vesey Street
New York, NY 10281-1023
(855) 777-8001
funds@brookfield.com

Investors should consider the Fund's investment objectives, risks, charges and expenses carefully before investing. The Fund's prospectus contains this and other information about the Fund and should be read carefully before investing. For further information regarding the Fund's rights offering, or to obtain a prospectus, when available, please contact the Fund's Information Agent:

AST Fund Solutions, LLC
55 Challenger Road, Suite 201
Ridgefield Park, NJ 07660
Banks and Brokers Call: 1-212-400-2605
Toll-Free: 1-866-297-6479

The information in this communication is not complete and may be changed. The Fund may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This communication is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

Brookfield Global Listed Infrastructure Income Fund Inc. Brookfield Place 250 Vesey Street New York, NY 10281-1023 (855) 777-8001 funds@brookfield.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 417

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 410

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 33

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 126

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 204

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 246

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuits Update for RTO and CUBI Investors

Updated Category News Views 221

Important Class Actions for Shareholders Investors should stay informed about the growing trend of class action lawsuits filed on behalf of shareholders in various publicly-traded companies. These lawsuits often arise from allegations of misleading statements made by the companies' management. Among the latest developments are cases involving Rentokil Initial plc (NASDAQ:...

Continue Reading
TransPerfect's GlobalLink Recognized for Excellence in Localization

Updated Category News Views 75

TransPerfect's GlobalLink Achieves Remarkable Recognition TransPerfect, the premier provider of language and AI solutions for global businesses, has achieved exceptional recognition with its GlobalLink platform. According to the G2 Fall 2024 Report, GlobalLink stands out as a top Enterprise Translation Management Software and Enterprise Website Translation Tool. This...

Continue Reading
Discover the Top U.S. Cities for Affordable Living Choices

Updated Category News Views 337

New Insights on Affordable Living in U.S. Cities A recent survey has ignited discussions on where to find the best cost-effective living environments across the United States. The research indicates a growing need for affordable housing that doesn’t forsake quality of life. In a world where the price of urban living continues to climb, this study by Advance America...

Continue Reading
Hilton USA Trust 2016-SFP CMBS: Navigating Upcoming Changes

Updated Category News Views 261

Understanding the Recent Changes in Hilton USA Trust 2016-SFP CMBS Investors holding the Hilton USA Trust 2016-SFP commercial mortgage pass-through certificates should be aware of significant upcoming changes regarding the special servicer of their loans. Recently, Wells Fargo Bank, N.A. has been involved in the management of these loans, which were placed under special...

Continue Reading
Exclusive CBD Agreement Between Avecho and Sandoz for Insomnia

Updated Category News Views 189

Exclusive Partnership Between Avecho and Sandoz Avecho Biotechnology Limited is thrilled to announce a groundbreaking partnership with Sandoz Group AG. This agreement marks a significant milestone for Avecho as it aims to commercialize its innovative cannabidiol capsule designed specifically for insomnia. With the exclusive license and development agreement now in place,...

Continue Reading